NOTICIAS
- Restoring brain immune balance opens new avenue for Alzheimer’s treatment
- Chronic stress may be quietly reshaping your heart
- Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation
- Scientists solve a 50-year mystery and discover a new human blood group
- How a single viral protein hijacks immune cells to supercharge COVID-19 infection
- B cells may help predict risk of colitis from immunotherapy
- Eating more eggs and peanuts while pregnant does not prevent infant allergies, clinical trial finds
- Big data analysis sheds light on psoriasis’s genetic code
- Teaching the immune system to control HIV
- Making invisible cancers visible: A new route to turn ‘cold’ tumors ‘hot’
- For people with a rare skin disorder, high allergy risk adds another burden
- Cancer biologists bring in the B-cell reinforcements for immunotherapy
- Boosted Bacille Calmette-Guérin vaccine strategy significantly reduces tuberculosis relapse, scientists find
- Dietitians release first nutrition-focused guide for alpha-gal syndrome
- Vaccination: Why don’t we all experience the same side effects?
- New mesothelioma drug turns cancer’s own defenses against it
PUBLICACIONES
- Restoring brain immune balance opens new avenue for Alzheimer’s treatment
- IL-21 boosts T cell-therapy efficacy for solid tumors by enhancing mitochondrial Ca2+-mediated motility of effector CD8+ T cells
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0
- NKG2A-HLA-E axis contributes to an immunosuppressive checkpoint network in hepatocellular carcinoma
- Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma
- Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment
- Chronic stress may be quietly reshaping your heart
- Cholesterol in hematological malignancies: metabolism, mechanisms, and clinical implications
- Mitochondrial dysfunction as a metabolic checkpoint of immunotherapy response in colorectal cancer
- Obesity-associated inflammation and cancer: molecular mechanisms, evidence gaps, and therapeutic opportunities
- Endometrial receptivity failure in assisted reproduction: immune-cellular niches, mechanistic evidence, and translational boundaries
- Macrophage-centered immune-fibrotic persistence in endometriosis and adenomyosis: non-hormonal immunopharmacological targets
- The infrapatellar fat pad–synovium immunometabolic interface in knee osteoarthritis: a local amplifier of joint inflammation
- Optimal timing of surgery after conversion therapy for initially unresectable hepatocellular carcinoma: a multicenter study integrating major pathological response and treatment duration
- Editorial: Infectious diseases in maternal-fetal interface: role of immune system to combat this pathology and avoid or minimize a possible vertical transmission
- BDE-47 and male infertility: integrated network toxicology, single-cell transcriptomics, and in vitro evidence of GSTM1 downregulation and ferroptosis-related molecular remodeling in Leydig cells
- Case Report: Observational use of mycophenolate mofetil in probable steroid-unresponsive immune checkpoint inhibitor-associated transverse myelitis
- The obesity paradox in primary Sjögren’s disease: immunometabolic associations of chemerin, platelet count, and statin use
- The neoantigen and associated tumour microenvironment in long-term survivors with oesophageal adenocarcinoma
- Dynamic regulation of hypoxia-associated regulatory CD39+CD73+ and IL35+ B cells in pancreatic cancer
- EV-derived miR-1246 promotes lymph node metastasis in esophageal squamous cell carcinoma through targeting the PPP2CB/NF-κB axis
- Thirty-five years of evolving inflammatory paradigms in sepsis (1991–2025): a comprehensive mapping of immune dysregulation research, anti-inflammatory targets, and translational barriers
- Development and external validation of an interpretable deep learning model for early immune-related adverse events in hepatocellular carcinoma
- Case Report: Nicotinamide monotherapy for infantile bullous pemphigoid with long-term follow-up
- STING-mediated tumor microenvironment remodeling: turning adaptive resistance into therapeutic vulnerability
- Identification of SARS-CoV-2-specific cytotoxic lymphocytes in cerebrospinal fluid of a patient with cerebral demyelination Post mRNA vaccination
- Cadonilimab alone as neoadjuvant immunotherapy followed by radical resection for dMMR/MSI-H gastric adenocarcinoma: a case report
- Development and evaluation of a dual-target glycoconjugate against Shigella sonnei
- Mitochondria affect antibacterial immunity in cross talk with innate immune response molecules coded by genes of nuclear origin
- Recurrent antibody repertoire features associated with six selected human IGHV genes: V(D)J usage, heavy-light pairing, and CDRH3 properties
- LGALS3 marks a pro-inflammatory, efferocytosis-low hepatic macrophage state and promotes hepatic stellate cell activation through the candidate receptor ANXA2 in liver cirrhosis
- Effectiveness and safety of belimumab and telitacicept in active systemic lupus erythematosus: a retrospective cohort study